The management of cutaneous squamous cell carcinoma (CSCC) is undergoing a notable shift, with systemic immunotherapy playing ...

Imaging is more sensitive than physical examination for nodal staging of cutaneous squamous cell carcinoma, according to a ...

Immunotherapy—particularly PD-1 inhibition with cemiplimab—is reshaping CSCC care by expanding into neoadjuvant and adjuvant ...

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, arising from abnormal proliferation of epidermal keratinocytes due to chronic UV exposure. While highly curable (>90%) ...

Switching to sirolimus significantly reduces the risk of subsequent cSCC in high-risk kidney transplant recipients with history of the skin cancer. Switching kidney transplant recipients (KTRs) with ...

What factors may put patients at an increased risk of cutaneous squamous cell carcinoma, and what should they know about ...